Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...
The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.
Vertex’s move for Alpine marks a turnaround in the fortunes ... and recently added to its portfolio with a therapy for blood disorders sickle cell disease (SCD) and transfusion-dependent beta ...
4d
Zacks.com on MSNVRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product SalesVertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $3.98 per share for the fourth quarter of 2024, ...
US skiers Mikaela Shiffrin and Breezy Johnson win gold in the team combined event at the Alpine world championships.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results